Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading-Reference-Cited by-同舟云学术

Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading

Published:2007-12 Issue:6 Volume:100 Page:1240-1244
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Berney Daniel M.,Fisher Gabrielle,Kattan Michael W.,Oliver R. Timothy D.,Møller Henrik,Fearn Paul,Eastham James,Scardino Peter,Cuzick Jack,Reuter Victor E.,Foster Christopher S.,

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2007.07199.x/fullpdf

Reference24 articles.

1. CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTS

2. Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer

3. The Patient’s Dilemma: Prostate Cancer Treatment Choices

4. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the center for prostate disease research nomograms

5. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer;American Journal of Clinical Pathology;2024-02-22

2. Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy;Cancer Reports;2021-08-22

3. Gleason Score Evolution and the Effect on Prostate Cancer Outcomes;American Journal of Clinical Pathology;2020-10-20

4. Trends in Diagnosis of Gleason Score 2 Through 4 Prostate Cancer in the National Cancer Database, 1990–2013;Archives of Pathology & Laboratory Medicine;2017-12-01

5. Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam;International Journal of Urology;2017-02-07